Sunshine Biopharma, Inc.
SBFM
$1.25
$0.032.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.13M | -4.23M | -3.68M | -4.09M | -4.51M |
| Total Depreciation and Amortization | 223.50K | 200.50K | 173.10K | 157.10K | 149.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.00K | 12.40K | 12.00K | 12.00K | 0.00 |
| Change in Net Operating Assets | -7.63M | -7.80M | -7.42M | -6.19M | -4.42M |
| Cash from Operations | -12.53M | -11.81M | -10.91M | -10.11M | -8.78M |
| Capital Expenditure | -1.66M | -1.17M | -664.60K | -145.10K | -82.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -300.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | 1.10K | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -663.80K | -886.50K | -796.60K | -1.03M | -573.90K |
| Cash from Investing | -2.32M | -2.06M | -1.46M | -1.18M | -656.10K |
| Total Debt Issued | 347.90K | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -120.80K | -120.40K | -124.20K | -126.10K |
| Issuance of Common Stock | 12.08M | 10.47M | 8.57M | 12.66M | 4.09M |
| Repurchase of Common Stock | -3.14M | -3.14M | -3.17M | -3.17M | -541.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.29M | 7.21M | 5.28M | 9.36M | 3.43M |
| Foreign Exchange rate Adjustments | -1.04M | 27.60K | -1.13M | 66.60K | 471.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.61M | -6.64M | -8.22M | -1.86M | -5.53M |